Jagsonpal Pharmaceuticals Limited (BOM:507789)
India · Delayed Price · Currency is INR 235.90
+2.15 (0.92%)
At close: Aug 21, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.59 billion as of August 21, 2026. Its market cap has decreased by -4.10% in one year.
Market Cap
15.59B
Enterprise Value
14.62B
Revenue
2.94B
Ranking
n/a
PE Ratio
34.29
Stock Price
235.90
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.59B, a decrease of -11.55%. That is a compound annual growth rate of -0.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 15.59B | 21.24% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suven Life Sciences | 98.21B |
| IOL Chemicals and Pharmaceuticals | 49.77B |
| Gujarat Themis Biosyn | 41.50B |
| Sai Parenteral's | 23.89B |
| NGL Fine-Chem | 18.28B |
| Bajaj HealthCare | 10.84B |
| Anlon Healthcare | 7.59B |
| Influx Healthtech | 6.76B |